Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation

British Journal of Anaesthesia

Volumn 113, Issue 1, 2014, Pages 194-195

  Coriat, P ^a   Guidet, B ^b   De Hert, S ^a   Kochs, E ^a   Kozek, S ^a   Van Aken, H ^a  

^a NONE   (Germany)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; SODIUM CHLORIDE; STARCH; HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE;

BLEEDING; BLOOD; BLOOD TRANSFUSION; BLUNT TRAUMA; EUROPEAN MEDICINES AGENCY; FLUID RESUSCITATION; HUMAN; HYPOVOLEMIA; HYPOVOLEMIC SHOCK; INTENSIVE CARE; LETTER; LICENSING; MORTALITY; PENETRATING TRAUMA; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK; FLUID THERAPY; NOTE; RESUSCITATION; STANDARD;

FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; PLASMA SUBSTITUTES; RESUSCITATION;

EID: 84905719206     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu217     Document Type: Letter

References (12)

1. Bellomo R, Bion J, Finfer S, Myburgh J, Perner A, Reinhart K. Open letter to the Executive Director of the European Medicine Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth 2014; 112: 595-600
2. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-39
3. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124-34
4. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-11
5. Supplement to: Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012. doi:10.1056/NEJMoa1209759
6. Van Der Linden P, James M, Mythen M, et al. Safety of modern starches used during surgery. Anesth Analg 2013; 116: 35-48
7. Martin C, Jacob M, Vicaut E, et al. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013; 118: 387-94
8. Annane D, Siami S, Jaber S, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock-the CRISTAL randomized trial. J Am Med Assoc 2013; 310: 1809-17
9. James MF, Michell WL, Joubert IA, et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011; 107: 693-702
10. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidneytransplant recipients. Lancet 1996; 348: 1620-22
11. Rational fluid therapy in Germany (RaFTinG). Available on Clinical-Trials.gov (NCT01122277) last updated on 7 July 2011. http://clinical trials.gov/ct2/show/NCT01122277?term=NCT01122277&rank=1
12. MeybohmP,Van Aken H,De Gasperi A, et al. Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl-starch in critically ill patients-A multidisciplinary statement. Crit Care 2013; 17: R166 (Epub ahead of print)